Nyxoah
John Landry is the Chief Financial Officer at Nyxoah since November 2024, bringing extensive financial leadership experience from previous roles, including Senior Vice President and CFO at Vapotherm from August 2012 to November 2024. Prior experience includes serving as Director of International Marketing for Advanced Energy at Medtronic, VP of Global Business Development at Salient Surgical Technologies, and various positions at Bottomline Technologies and Hussey Seating Company. Landry began their career as a Senior Associate at PwC after earning a Bachelor of Science in Accountancy from Bentley University in 1994.
This person is not in any teams
This person is not in any offices
Nyxoah
Nyxoah is a medical device company focused on the development and commercialization of a hypoglossal nerve stimulation (HGNS) therapy.